Cargando…

Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

INTRODUCTION: The c-Jun coactivator, Jun activation-domain binding protein 1 (Jab1) also known as the fifth component of the COP9 signalosome complex (CSN5), is a novel candidate oncogene whose aberrant expression contributes to the progression of breast carcinoma and other human cancers. The mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shackleford, Terry J, Zhang, Qingxiu, Tian, Ling, Vu, Thuy T, Korapati, Anita L, Baumgartner, Angela M, Le, Xiao-Feng, Liao, Warren S, Claret, Francois X
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218954/ https://www.ncbi.nlm.nih.gov/pubmed/21689417 http://dx.doi.org/10.1186/bcr2902

Ejemplares similares

JAB1/CSN5: a new player in cell cycle control and cancer
por: Shackleford, Terry J, et al.
Publicado: (2010)

Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression
por: Pan, Yunbao, et al.
Publicado: (2016)

Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
por: Pan, Yunbao, et al.
Publicado: (2012)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
por: Xagoraris, I., et al.
Publicado: (2022)

Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma
por: Ma, Weijie, et al.
Publicado: (2021)

Hsa-miR-24-3p Increases Nasopharyngeal Carcinoma Radiosensitivity by Targeting Both the 3’UTR and 5’UTR of Jab1/CSN5
por: Wang, Sumei, et al.
Publicado: (2016)

Sulforaphene Suppresses Adipocyte Differentiation via Induction of Post-Translational Degradation of CCAAT/Enhancer Binding Protein Beta (C/EBPβ)
por: Yang, Hee, et al.
Publicado: (2020)

Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation
por: Kim, Myung Sup, et al.
Publicado: (2023)

Developmental expression of p97/VCP (Valosin-containing protein) and Jab1/CSN5 in the rat testis and epididymis
por: Cayli, Sevil, et al.
Publicado: (2011)

The Antioxidant Enzyme Methionine Sulfoxide Reductase A (MsrA) Interacts with Jab1/CSN5 and Regulates Its Function
por: Jiang, Beichen, et al.
Publicado: (2020)

Jab
por: Boggon, Adam
Publicado: (2022)

Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels
por: Cope, Gregory A, et al.
Publicado: (2006)

COP9 Signalosome Component JAB1/CSN5 Is Necessary for T Cell Signaling through LFA-1 and HIV-1 Replication
por: Kinoshita, Shigemi M., et al.
Publicado: (2012)

Interaction between parasite-encoded JAB1/CSN5 and macrophage migration inhibitory factor proteins attenuates its proinflammatory function
por: Ghosh, Swagata, et al.
Publicado: (2018)

Stat3 and CCAAT enhancer–binding protein β (C/ebpβ) activate Fanconi C gene transcription during emergency granulopoiesis
por: Shah, Chirag A., et al.
Publicado: (2018)

α5‐nAChR contributes to epithelial‐mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Free flu jabs for dentists jabs axed by NHS England
Publicado: (2022)

Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
por: Liu, Guohong, et al.
Publicado: (2018)

CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation
por: Yu, Xueyan, et al.
Publicado: (2010)

The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPβ during epithelial tumour progression
por: Sundfeldt, K, et al.
Publicado: (1999)

CSN
Publicado: (1991)

CCAAT/enhancer binding proteins in normal mammary development and breast cancer
por: Zahnow, Cynthia A
Publicado: (2002)

Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia
por: Marchildon, François, et al.
Publicado: (2015)

Cyclic regulation of transcription factor C/EBP beta in human endometrium
por: Plante, Beth J, et al.
Publicado: (2009)

The Impact of the No Jab No Play and No Jab No Pay Legislation in Australia: A Scoping Review
por: Burns, Sharyn, et al.
Publicado: (2023)

Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPα) p42 versus p30 may contribute in part, to aberrant C/EBPα activity in acute leukemias
por: Hankey, William, et al.
Publicado: (2011)

Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment
por: Iwama, Atsushi, et al.
Publicado: (2002)

CCAAT/enhancer-binding protein δ (C/EBPδ) aggravates inflammation and bacterial dissemination during pneumococcal meningitis
por: Serón, Mercedes Valls, et al.
Publicado: (2015)

CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis
por: JanWillem, Duitman, et al.
Publicado: (2018)

CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia
por: Marchildon, F, et al.
Publicado: (2016)

Molecular Characterization of the Llamas (Lama glama) Casein Cluster Genes Transcripts (CSN1S1, CSN2, CSN1S2, CSN3) and Regulatory Regions
por: Pauciullo, Alfredo, et al.
Publicado: (2015)

5’-flanking variants of equine casein genes (CSN1S1, CSN1S2, CSN2, CSN3) and their relationship with gene expression and milk composition
por: Cieslak, Jakub, et al.
Publicado: (2018)

The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide
por: Ramberg, Veronica, et al.
Publicado: (2011)

SAT-333 CCAAT Enhancer Binding Protein Β(C/EBPΒ)-induced Axl in Early Breast Cancer Progression
por: Burke, Caitlin, et al.
Publicado: (2019)

Expression of CAAT Enhancer Binding Protein Beta (C/EBP β) in Cervix and Endometrium
por: Arnett, Brenda, et al.
Publicado: (2003)

CCAAT/enhancer-binding protein beta (C/EBPβ) is an important mediator of 1,25 dihydroxyvitamin D3 (1,25D3)-induced receptor activator of nuclear factor kappa-B ligand (RANKL) expression in osteoblasts
por: Jo, Sungsin, et al.
Publicado: (2019)

Protein-x of hepatitis B virus in interaction with CCAAT/enhancer-binding protein α (C/EBPα) - an in silico analysis approach
por: Mohamadkhani, Ashraf, et al.
Publicado: (2011)

CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma
por: Sowamber, Ramlogan, et al.
Publicado: (2019)

Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qaagocs9f1lj7ds1sorlkh4u90